Making the Most of Academic Drug-Target Discoveries

By Richard Reschen, Isis Innovation Limited, the technology transfer company of the University of Oxford

The explosion of new technologies and research techniques, and encouragement from funding agencies for academic institutions to undertake more translational research, has led universities to devote greater resources toward applied drug-discovery activity. Therefore, universities and academic institutions are discovering an increasing number of drug targets. These are molecules, often proteins (such as enzymes or cell surface receptors), that could potentially be manipulated by chemical or biological entities to treat disease.

*This article appeared in the March 2015 issue of les Nouvelles.


Upcoming Events

LES Events Worldwide

All LES Events

LES Member Directory

Click here to access the LES membership directory.

Licensing Resource Guide
New IP Business Models: Innovation or Commoditization?